cNeuro
  • Main
  • News
  • Products
    • cNeuro® cMRI
    • cNeuro® cDSI
  • Team
  • Contact
  • Login to cNeuro
    • US Login
    • EU login
Select Page

FDA clears Combinostics’ MRI quantification software cNeuro cMRI

Jan 15, 2018

Tampere January 15, 2018 – The digital health company Combinostics received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its image quantification software cNeuro cMRI. The software enables clinicians to get objective measurements of atrophy in...

Recent Posts

  • Visit our booth at RSNA 2020
  • Combinostics extends cNeuro® platform with tools for web-based cognitive testing
  • Come and meet us at ACTRIMS
  • Visit our booth at AAIC
  • Combinostics extends cDSI in collaboration with the Alzheimer Center Amsterdam

Archives

  • November 2020
  • September 2020
  • August 2020
  • July 2020
  • January 2020
  • November 2019
  • July 2019
  • February 2019
  • January 2019
  • October 2018
  • July 2018
  • June 2018
  • April 2018
  • March 2018
  • January 2018
  • November 2017
  • July 2017
  • December 2016
  • September 2016

Categories

  • Awards
  • Conferences
  • Partnerships
  • Publications
  • Regulatory
  • Releases
  • Uncategorised

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

is a product by

Sales

Lennart Thurfjell

Technical

Jussi Mattila

Science

Jyrki Lötjönen

OUR OFFICE

Combinostics Oy
Hatanpään valtatie 24
33100 Tampere, FINLAND

Email: first.last@combinostics.com

Privacy Policy

Copyright Combinostics 2017